Generation of the Novel Anti-FXYD5 Monoclonal Antibody and Its Application to the Diagnosis of Pancreatic and Lung Cancer

To generate specific antibodies that bind to proteins expressed on the surface of pancreatic cancer cells, scientists immunized mice with human pancreatic cancer MIA PaCa-2 cells, and isolated a hybridoma that produces a monoclonal antibody (mAb), named 12–13.8.